← Leaderboards
Kathryn Ann Gold
University Of Tx Md Anderson Can Ctr
$1,170,673
Attributed
$2,265,654
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $768.4K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,265,654 · 3
By mechanism
R01$2,019,485 · 2
P30$246,169 · 1
Top collaborators
- Judith A. Varner3 shared
- Bingliang Fang1 shared
- John V. Heymach1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Heath Devin Skinner$8,539,031
- Abdullah Ali Osman$1,994,753
- Michael W Andreeff$17,991,896
- Guojun Li$2,468,355
- Padmanee Sharma$2,235,712
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorTherapeutic TargetMouse ModelCellsClinical TrialsMonitorResistanceImmunotherapyCd8-Positive T-LymphocytesImmunooncologyImmune ResponseAnti-Tumor Immune ResponseImmunosuppressionImproved OutcomeImmuneDeveloping CountriesFutureImmune Checkpoint InhibitorEffector T CellHead And Neck Squamous Cell CarcinomaHuman PapillomavirusCancer PatientArginase
Grant awards (5)
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC$522,215
R01 · FY2025 · CA
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC$522,215
R01 · FY2024 · CA
Clinical Protocol and Data Management$246,169
P30 · FY2024 · CA · contact PI
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC$463,621
R01 · FY2022 · CA
Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing$511,434
R01 · FY2015 · CA